These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 8894115)

  • 21. Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans.
    Kassahun K; Farrell K; Abbott F
    Drug Metab Dispos; 1991; 19(2):525-35. PubMed ID: 1676665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetramethylcyclopropyl analogue of the leading antiepileptic drug, valproic acid: evaluation of the teratogenic effects of its amide derivatives in NMRI mice.
    Okada A; Onishi Y; Yagen B; Shimshoni JA; Kaufmann D; Bialer M; Fujiwara M
    Birth Defects Res A Clin Mol Teratol; 2008 Sep; 82(9):610-21. PubMed ID: 18671279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of valproic acid on glycine conjugation of benzoic acid.
    Gregus Z; Fekete T; Varga F; Klaassen CD
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1068-75. PubMed ID: 8263766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and anticonvulsant evaluation of dimethylethanolamine analogues of valproic acid and its tetramethylcyclopropyl analogue.
    Shekh-Ahmad T; Bialer M; Yavin E
    Epilepsy Res; 2012 Feb; 98(2-3):238-46. PubMed ID: 22057163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disposition of valproic acid in maternal, fetal, and newborn sheep. II: metabolism and renal elimination.
    Kumar S; Wong H; Yeung SA; Riggs KW; Abbott FS; Rurak DW
    Drug Metab Dispos; 2000 Jul; 28(7):857-64. PubMed ID: 10859160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide diconjugates.
    Tang W; Abbott FS
    Chem Res Toxicol; 1996 Mar; 9(2):517-26. PubMed ID: 8839057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxamic acid and fluorinated derivatives of valproic acid: anticonvulsant activity, neurotoxicity and teratogenicity.
    Gravemann U; Volland J; Nau H
    Neurotoxicol Teratol; 2008; 30(5):390-4. PubMed ID: 18455366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticonvulsant profile and teratogenicity of 3,3-dimethylbutanoylurea: a potential for a second generation drug to valproic acid.
    Shimshoni JA; Yagen B; Pessah N; Wlodarczyk B; Finnell RH; Bialer M
    Epilepsia; 2008 Jul; 49(7):1202-12. PubMed ID: 18435754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of alpha-fluorinated valproic acid in mouse brain and serum and its effect on synaptosomal gamma-aminobutyric acid levels in comparison to valproic acid.
    Tang W; Palaty J; Abbott FS
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1163-72. PubMed ID: 9316822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of valproate, vigabatrin and tiagabine on GABA uptake into human astrocytes cultured from foetal and adult brain tissue.
    Fraser CM; Sills GJ; Butler E; Thompson GG; Lindsay K; Duncan R; Howatson A; Brodie MJ
    Epileptic Disord; 1999 Sep; 1(3):153-7. PubMed ID: 10937147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of central nervous system-active valproic acid constitutional isomers, cyclopropyl analogs, and amide derivatives on neuronal growth cone behavior.
    Shimshoni JA; Dalton EC; Jenkins A; Eyal S; Ewan K; Williams RS; Pessah N; Yagen B; Harwood AJ; Bialer M
    Mol Pharmacol; 2007 Mar; 71(3):884-92. PubMed ID: 17167030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamic and/or pharmacokinetic characteristics of interactions between loreclezole and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis.
    Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsy Behav; 2005 Dec; 7(4):639-51. PubMed ID: 16140589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods.
    Lampen A; Göttlicher M; Nau H
    ALTEX; 2001; 18(2):123-6. PubMed ID: 11378687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticonvulsant activity, neural tube defect induction, mutagenicity and pharmacokinetics of a new potent antiepileptic drug, N-methoxy-2,2,3,3-tetramethylcyclopropane carboxamide.
    Sobol E; Yagen B; Lamb JG; White HS; Wlodarczyk BJ; Finnell RH; Bialer M
    Epilepsy Res; 2007 Jan; 73(1):75-84. PubMed ID: 16997532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic analysis and anticonvulsant activity of two polyesteric prodrugs of valproic acid.
    Hadad S; Vree TB; van der Kleijn E; Bialer M
    Biopharm Drug Dispos; 1993 Jan; 14(1):51-9. PubMed ID: 8427944
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution of valproic acid and its metabolites in various brain areas of dogs and rats after acute and prolonged treatment.
    Löscher W; Nau H
    J Pharmacol Exp Ther; 1983 Sep; 226(3):845-54. PubMed ID: 6411902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P-450-mediated dehydrogenation of 2-n-propyl-2(E)-pentenoic acid, a pharmacologically-active metabolite of valproic acid, in rat liver microsomal preparations.
    Kassahun K; Baillie TA
    Drug Metab Dispos; 1993; 21(2):242-8. PubMed ID: 8097692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification and characterization of N-acetylcysteine conjugates of valproic acid in humans and animals.
    Gopaul SV; Farrell K; Abbott FS
    Drug Metab Dispos; 2000 Jul; 28(7):823-32. PubMed ID: 10859157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute effects of N-(2-propylpentanoyl)urea on hippocampal amino acid neurotransmitters in pilocarpine-induced seizure in rats.
    Khongsombat O; Watanabe H; Tantisira B; Patarapanich C; Tantisira MH
    Epilepsy Res; 2008 May; 79(2-3):151-7. PubMed ID: 18439803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Valproyl-dephosphoCoA: a novel metabolite of valproate formed in vitro in rat liver mitochondria.
    Silva MF; Ijlst L; Allers P; Jakobs C; Duran M; de Almeida IT; Wanders RJ
    Drug Metab Dispos; 2004 Nov; 32(11):1304-10. PubMed ID: 15483197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.